LMNL - The best places to buy Liminal BioSciences stock after its 35% uptick
Liminal BioSciences (NASDAQ: LMNL) is one of the best-performing stocks on the public market today.
If you want to invest in Liminal BioSciences, or if you simply want to find out more about the company and why it is surging in value, this article should answer all of your questions. Read on to find out what you need to know.
First things first, if you want to buy Liminal BioSciences stock today, check out the section immediately below. There, you can see our list of the best places to buy Liminal BioSciences shares in the UK and around the world.
How & where to buy LMNL stock online
To buy shares in Liminal BioSciences, scroll down to the links below and choose one. Then, create an account, deposit funds, and purchase the number of shares you want to own.
Here are the two best platforms to buy Liminal BioSciences shares right now:
eToro
eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.
Webull
Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.
Register with Webull instantly
What is Liminal BioSciences?
Incorporated in 1994 and headquartered in Laval, Canada, it is a clinical-stage biopharmaceutical company. Liminal is focussed on the discovery, development, and commercialisation of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high unmet medical needs.
The price of LMNL stock has surged on heavy volume following positive news that Liminal’s subsidiary, Prometic Biotherapeutics Inc. (PBT), has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $105 million.
Should I buy Liminal BioSciences stock today?
If you have done your own research and think this sale could spell growth for Liminal, buying shares now could be a good way to speculate on their future value. Just make sure you are aware of the risks of investing and that these are increased when dealing with biopharmaceutical stocks.
Liminal BioSciences price target 2021
Our 12-month LMNL price target is as follows: a high of $5.50, a median of $4.85 and a low of $2.80.
The post The best places to buy Liminal BioSciences stock after its 35% uptick appeared first on Invezz .